- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1573-7209
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Erratum to: miRNAs: micro-managers of anticancer combination therapies ; day:19 ; month:7 ; year:2017 ; pages:1
Angiogenesis ; (19.7.2017), 1
- Keyword
-
Krebs
Onkologie
- Creator
-
Beijnum, Judy R. van
- Contributor
-
Giovannetti, Elisa
Poel, Dennis
Nowak-Sliwinska, Patrycja
Griffioen, Arjan W.
SpringerLink (Online service)
- DOI
-
10.1007/s10456-017-9564-7
- URN
-
urn:nbn:de:1111-201708231922
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:49 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Beijnum, Judy R. van
- Giovannetti, Elisa
- Poel, Dennis
- Nowak-Sliwinska, Patrycja
- Griffioen, Arjan W.
- SpringerLink (Online service)
Other Objects (12)
Development of novel parvovirus-based anticancer therapies
Optimization of personalized therapies for anticancer treatment
Assessing the economic value of anti-cancer therapies
Ocular side effects of novel anti-cancer biological therapies
Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies
Clinical development of targeted and immune based anti-cancer therapies
A systematic review of non-standard dosing of oral anticancer therapies
Autophagy manipulation as a strategy for efficient anticancer therapies: possible consequences
Dual RNase activity of IRE1 as a target for anticancer therapies
Association between the antioxidant properties of SESN proteins and anti-cancer therapies
Tackling the tumor microenvironment: what challenge does it pose to anticancer therapies?
Cancer-associated fibroblasts and resistance to anticancer therapies: status, mechanisms, and countermeasures
Development of novel parvovirus-based anticancer therapies
Optimization of personalized therapies for anticancer treatment
Assessing the economic value of anti-cancer therapies
Ocular side effects of novel anti-cancer biological therapies
Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies
Clinical development of targeted and immune based anti-cancer therapies
A systematic review of non-standard dosing of oral anticancer therapies
Autophagy manipulation as a strategy for efficient anticancer therapies: possible consequences
Dual RNase activity of IRE1 as a target for anticancer therapies
Association between the antioxidant properties of SESN proteins and anti-cancer therapies
Tackling the tumor microenvironment: what challenge does it pose to anticancer therapies?
Cancer-associated fibroblasts and resistance to anticancer therapies: status, mechanisms, and countermeasures
Development of novel parvovirus-based anticancer therapies
Optimization of personalized therapies for anticancer treatment
Assessing the economic value of anti-cancer therapies
Ocular side effects of novel anti-cancer biological therapies
Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies
Clinical development of targeted and immune based anti-cancer therapies
A systematic review of non-standard dosing of oral anticancer therapies
Autophagy manipulation as a strategy for efficient anticancer therapies: possible consequences
Dual RNase activity of IRE1 as a target for anticancer therapies
Association between the antioxidant properties of SESN proteins and anti-cancer therapies
Tackling the tumor microenvironment: what challenge does it pose to anticancer therapies?